05/23/2017 - 4:46pm

According to the agency, this is the first time it has approved a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated.

05/23/2017 - 4:01pm
CVS Health president and CEO Larry Merlo was the guest on Boston’s WBUR radio station’s “Here & Now” Tuesday, speaking with host Jeremy Hobson about such topics as tax reform, Amazon’s potential entry into pharmacy and the ongoing question of what changes will come to health care as the Senate considers the American Health Care Act. “I think there are elements that make sense from the Republican plan, but clearly there are other elements the Republican plan does not deal with,” Merlo said. “I think there are many open questions that have yet to be answered” (WBUR)
05/23/2017 - 2:40pm

The retailer welcomed Arizona Attorney General Mark Brnovich and State Rep. Heather Carter on Tuesday.

05/23/2017 - 11:59am

Walgreens is focusing more on health, wellness and beauty and it attempts to draw pharmacy customers to the front end.

05/23/2017 - 11:35am

Roughly three-quarters of visitors to the online platform are taking active follow-up steps, the retailer announced Tuesday, noting that its digital mental health resources also are reaching a broader demographic of consumers.

05/23/2017 - 10:37am

“Pharmacists need to understand what’s happening around them regarding the availability of precision medicines and their profiles,” Murray Aitken, executive director of the Quintiles IMS Institute and co-author of the report, said during the International Pharmaceutical Federation 6th Pharmaceutical Sciences World Congress.

05/22/2017 - 3:06pm

The Food and Drug Administration has approved Aurobindo’s generic of Daiichi Sankyo’s Azor and its generic of Pfizer’s Glucotrol XL.  

05/22/2017 - 2:30pm

Among NCPA’s comments were notes about what it sees as the need to address direct and indirect remuneration, or DIR, fees; requests to standardize how Medicare Part D plans measure pharmacy quality; and other efforts to improve patient access to medication and pharmacy services

05/22/2017 - 1:44pm

Hoffman La Roche’s drug takes aim at the form of vasculitis, a group of disorders that results in inflammation of blood vessels.